SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPollen Street Regulatory News (POLN)

Share Price Information for Pollen Street (POLN)

Share Price is delayed by 15 minutes
Get Live Data
867.00    15.00 (1.76%)
Bid:
867.00
Ask:
873.00
Spread: 6.00 (0.692%)
Market Cap: £515.62m
POLN Live PriceLast checked at - London Stock Exchange

Intraday Pollen Street Share Chart

Directorate changes

30 Jan 2026 10:59

RNS Number : 1189R
Pollen Street Group Limited
30 January 2026
Β 

30 January 2026

Pollen Street Group Limited

("Pollen Street" or the "Company")

Directorate Changes

Β 

The Company announces the following changes to its Board of Directors.

Appointment of Independent Non-Executive Director

The Company confirms the appointment of Robert Ohrenstein as an independent Non-Executive Director, effective from 29 January, 2026. Upon joining the Board, Mr Ohrenstein will also become a member of the Audit and Risk Committees.

Retirement of Senior Independent Director and Audit Committee Chair

As previously disclosed, Jim Coyle, Senior Independent Director and Chair of the Audit Committee, will retire from the Board at the Annual General Meeting to be held in April 2026 following the completion of his nine-year tenure.

Committee and Board Role Transitions

Following Mr Coyle's retirement, Mr Ohrenstein will be appointed Chair of the Audit Committee with effect from 1 May 2026. In addition, Richard Rowney (Independent Non-Executive Director and Risk Committee Chair) will be appointed as Senior Independent Director from 1 May 2026.

About Robert Ohrenstein

Mr Ohrenstein brings extensive private equity and financial knowledge with over three decades of experience in financial and professional services. Mr Ohrenstein was Global Head of Private Equity at KPMG for almost ten years, and most recently was a UK Vice Chair. At KPMG, he set the firm's global private equity strategy including formulating and implementing a major global investment plan for the firm. Mr Ohrenstein holds an MBA from the University of Warwick and a BSc (Econ) from the London School of Economics. He is a Fellow of the Institute of Chartered Accountants in England and Wales. He currently serves as Non-Executive Director and Audit Committee Chair of PTSG Group Ltd, is an Operations Adviser for Advent International, and acts as senior adviser to a number of Private Equity firms.

Lynn Fordham, Chair of Pollen Street, said: "Jim has made an exceptional contribution to the Board over the course of his tenure and I would like to thank him for his commitment and leadership, particularly in his role as Chair of the Audit Committee.

We are pleased to welcome Robert to the Board. His depth of experience and financial expertise will be a valuable addition as the Company continues to execute its strategy and maintain high standards of governance."

Lindsey McMurray, CEO of Pollen Street, added: "I would like to thank Jim for his hard work and valuable support during his years on the Board. We are pleased to welcome Robert and look forward to the experience and perspective he brings as we continue to build the business."

Robert Ohrenstein commented: "Pollen Street has established a strong platform and a clear strategic focus. I am excited to be taking on this role and look forward to working with the Board and management team to help drive the Company's continued growth and, in my role as Chair of the Audit Committee, to supporting its high governance standards as the business develops."

The Company makes this announcement in accordance with LR 6.4.8 of theΒ UKΒ Listing Rules. There are no other matters to be disclosed underΒ LR 6.4.8.

About Pollen Street

Pollen Street is an alternative asset manager dedicated to investing within the financial and business services sectors across both Private Equity and Private Credit strategies. Founded in 2013, the Group has consistently delivered top-tier returns alongside growing AuM.

Pollen Street operates through two complementary segments: the Asset Manager, which manages third-party AuM, and the Investment Company, which invests on balance sheet to generate attractive returns and accelerate AuM growth through alignment with investors.

POLN is listed on the London Stock Exchange (ticker symbol: POLN) and is a member of the FTSE 250 index. Further details are available at www.pollenstreetgroup.com

Β 

For further information about this announcement please contact:

Β 

Pollen Street - Corporate Development Director

Shweta Chugh

+44 (0)20 3965 5081

Β 

Barclays Bank plc - Joint Broker

Neal West / Stuart Muress

+44 (0)20 7623 2323

Β 

Investec Bank plc - Joint Broker

Ben Griffiths / Kamalini Hull

+44 (0)20 7597 4000

Β 

FGS Global

Chris Sibbald / Anna Tabor

PollenStreetCapital-LON@fgsglobal.com

Β 

MUFG Corporate Governance Limited

Company Secretary

POLNcosec@cm.mpms.mufg.com

Β 

LEI 894500LP94M98N8CY487Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
BOAWPUMAGUPQGUU
Date   Source Headline
1st Jun 20263:01 pmRNSTotal Voting Rights
27th May 20264:46 pmRNSDirector/PDMR Shareholding
27th May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
11th May 20265:39 pmRNSDirector/PDMR Shareholding
7th May 20267:00 amRNSQ1 2026 Trading Update
6th May 20264:40 pmRNSDirector/PDMR Shareholding
1st May 20269:49 amRNSTotal Voting Rights
1st May 20268:12 amRNSResult of AGM
28th Apr 20264:31 pmRNSDirector/PDMR Shareholding
16th Apr 20265:31 pmRNSInvestor Presentation via Investor Meet Company
14th Apr 20267:00 amRNSHolding(s) in Company
10th Apr 20267:00 amRNSTransaction in Own Shares
27th Mar 202610:36 amRNSDirector/PDMR Shareholding
26th Mar 20264:37 pmRNSDirector/PDMR Shareholding
26th Mar 20267:30 amRNSDividend Declaration
26th Mar 20267:00 amRNSFull Year 2025 Trading Update
2nd Mar 202611:26 amRNSTotal Voting Rights
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20261:57 pmRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
25th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:00 amRNSTransaction in Own Shares
18th Feb 20267:00 amRNSTransaction in Own Shares
17th Feb 20267:00 amRNSTransaction in Own Shares
13th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20264:32 pmRNSDirector/PDMR Shareholding
2nd Feb 20263:12 pmRNSTotal Voting Rights
30th Jan 202610:59 amRNSDirectorate changes
28th Jan 202611:37 amRNSDirector/PDMR Shareholding
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 20267:00 amRNSDirectorate change
23rd Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
15th Jan 20267:00 amRNSTransaction in Own Shares
2nd Jan 20267:00 amRNSTotal Voting Rights
30th Dec 20254:27 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20259:50 amRNSUpdate Statement on 2025 AGM Voting Results
1st Dec 202511:15 amRNSTotal Voting Rights
28th Nov 20256:23 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSQ3 2025 Trading Update
17th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSAnnouncement of New Share Buyback Programme
16th Oct 20256:16 pmRNSHolding(s) in Company
3rd Oct 202511:32 amRNSDirector/PDMR Shareholding
1st Oct 20255:12 pmRNSDirector/PDMR Shareholding
30th Sep 20254:07 pmRNSInvestor Presentation via Investor Meet Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.